2006 - Fellow of the Royal Society of Canada Academy of Science
Ernesto L. Schiffrin spends much of his time researching Internal medicine, Endocrinology, Blood pressure, Angiotensin II and Endothelium. His biological study deals with issues like Cardiology, which deal with fields such as Renovascular hypertension. His Endothelin receptor research extends to the thematically linked field of Endocrinology.
His work in the fields of Atenolol overlaps with other areas such as Risk assessment. His Angiotensin II research integrates issues from Inflammation, Vascular resistance and NAD+ kinase. His Endothelium research is multidisciplinary, relying on both Endothelial stem cell, Mesenteric arteries, Nitric oxide and Vasodilation.
Ernesto L. Schiffrin mostly deals with Internal medicine, Endocrinology, Blood pressure, Angiotensin II and Renin–angiotensin system. Endothelin receptor, Endothelium, Endothelin 1, Endothelial dysfunction and Aldosterone are subfields of Internal medicine in which his conducts study. His Endothelial dysfunction research is multidisciplinary, incorporating perspectives in Oxidative stress and Vasodilation.
His Endocrinology study incorporates themes from Receptor and Mesenteric arteries. His Blood pressure research focuses on subjects like Blood vessel, which are linked to Circulatory system. Immune system is closely connected to Inflammation in his research, which is encompassed under the umbrella topic of Angiotensin II.
His primary scientific interests are in Internal medicine, Endocrinology, Blood pressure, Angiotensin II and Endothelin 1. The study incorporates disciplines such as Diabetes mellitus and Cardiology in addition to Internal medicine. He focuses mostly in the field of Endocrinology, narrowing it down to matters related to Human endothelin and, in some cases, Gene expression.
His Blood pressure research includes themes of MEDLINE, Guideline, Family medicine, Emergency medicine and Disease. As a part of the same scientific study, Ernesto L. Schiffrin usually deals with the Angiotensin II, concentrating on Immune system and frequently concerns with Monocyte and Pathophysiology of hypertension. His studies deal with areas such as Peroxisome proliferator-activated receptor and Vasodilation as well as Vascular smooth muscle.
His primary areas of study are Blood pressure, Internal medicine, Endocrinology, Immune system and Endothelial dysfunction. His Blood pressure study combines topics in areas such as Stroke, Guideline, Disease and Emergency medicine. Many of his studies involve connections with topics such as Cardiology and Internal medicine.
His primary area of study in Endocrinology is in the field of Endothelium. His research integrates issues of Inflammation, Angiotensin II, Pathophysiology of hypertension and Monocyte in his study of Immune system. His Endothelin receptor research focuses on Kidney and how it relates to Mesenteric arteries.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
Salvatore Mottillo;Kristian B. Filion;Jacques Genest;Lawrence Joseph.
Journal of the American College of Cardiology (2010)
Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension
Michael A. Weber;Ernesto L. Schiffrin;William B. White;Samuel Mann.
Journal of Hypertension (2014)
Chronic Kidney Disease Effects on the Cardiovascular System
Ernesto L. Schiffrin;Mark L. Lipman;Johannes F.E. Mann.
Vascular Remodeling in Hypertension Roles of Apoptosis, Inflammation, and Fibrosis
Hope D. Intengan;Ernesto L. Schiffrin.
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Rhian M. Touyz;Ernesto L. Schiffrin.
Pharmacological Reviews (2000)
Endothelial dysfunction : Mechanisms of hypertension: Cells, hormones, and the kidney
Dierk H. Endemann;Ernesto L. Schiffrin.
Journal of The American Society of Nephrology (2004)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the working group on endothelin and endothelial factors of the European society of hypertension
John Deanfield;Ann Donald;Claudio Ferri;Cristina Giannattasio.
Journal of Hypertension (2005)
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan
Ernesto L. Schiffrin;Jeong Bae Park;Hope D. Intengan;Rhian M. Touyz.
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association
Raymond R. Townsend;Ian B. Wilkinson;Ernesto L. Schiffrin;Alberto P. Avolio.
Reactive oxygen species in vascular biology: implications in hypertension
R. M. Touyz;E. L. Schiffrin.
Histochemistry and Cell Biology (2004)
American Journal of Hypertension
(Impact Factor: 3.08)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: